High-Dose celecoxib and metronomic "low-dose" cyclophosphamide is an effective and safe therapy in patients with relapsed and refractory aggressive histology non-Hodgkin's lymphoma. (Q53250395)

From Wikidata

Jump to navigation Jump to search

scientific article published in September 2006

edit

Language	Label	Description	Also known as
English	High-Dose celecoxib and metronomic "low-dose" cyclophosphamide is an effective and safe therapy in patients with relapsed and refractory aggressive histology non-Hodgkin's lymphoma.	scientific article published in September 2006

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16951238

retrieved

12 May 2018

reference URL

http://europepmc.org/abstract/MED/16951238

title

High-Dose celecoxib and metronomic "low-dose" cyclophosphamide is an effective and safe therapy in patients with relapsed and refractory aggressive histology non-Hodgkin's lymphoma. (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16951238

retrieved

12 May 2018

reference URL

http://europepmc.org/abstract/MED/16951238

main subject

patient

0 references

author name string

Rena Buckstein

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16951238

retrieved

12 May 2018

reference URL

http://europepmc.org/abstract/MED/16951238

Robert S Kerbel

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16951238

retrieved

12 May 2018

reference URL

http://europepmc.org/abstract/MED/16951238

Yuval Shaked

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16951238

retrieved

12 May 2018

reference URL

http://europepmc.org/abstract/MED/16951238

Rakesh Nayar

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16951238

retrieved

12 May 2018

reference URL

http://europepmc.org/abstract/MED/16951238

Cindy Foden

series ordinal

5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16951238

retrieved

12 May 2018

reference URL

http://europepmc.org/abstract/MED/16951238

Ruth Turner

series ordinal

6

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16951238

retrieved

12 May 2018

reference URL

http://europepmc.org/abstract/MED/16951238

Christine R Lee

series ordinal

7

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16951238

retrieved

12 May 2018

reference URL

http://europepmc.org/abstract/MED/16951238

Diane Taylor

series ordinal

8

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16951238

retrieved

12 May 2018

reference URL

http://europepmc.org/abstract/MED/16951238

Liying Zhang

series ordinal

9

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16951238

retrieved

12 May 2018

reference URL

http://europepmc.org/abstract/MED/16951238

Shan Man

series ordinal

10

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16951238

retrieved

12 May 2018

reference URL

http://europepmc.org/abstract/MED/16951238

Sylvain Baruchel

series ordinal

11

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16951238

retrieved

12 May 2018

reference URL

http://europepmc.org/abstract/MED/16951238

Diana Stempak

series ordinal

12

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16951238

retrieved

12 May 2018

reference URL

http://europepmc.org/abstract/MED/16951238

Francesco Bertolini

series ordinal

13

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16951238

retrieved

12 May 2018

reference URL

http://europepmc.org/abstract/MED/16951238

Michael Crump

series ordinal

14

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16951238

retrieved

12 May 2018

reference URL

http://europepmc.org/abstract/MED/16951238

language of work or name

English

0 references

publication date

1 September 2006

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16951238

retrieved

12 May 2018

reference URL

http://europepmc.org/abstract/MED/16951238

published in

Clinical Cancer Research

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16951238

retrieved

12 May 2018

reference URL

http://europepmc.org/abstract/MED/16951238

volume

12

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16951238

retrieved

12 May 2018

reference URL

http://europepmc.org/abstract/MED/16951238

issue

17

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16951238

retrieved

12 May 2018

reference URL

http://europepmc.org/abstract/MED/16951238

page(s)

5190-5198

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16951238

retrieved

12 May 2018

reference URL

http://europepmc.org/abstract/MED/16951238

Identifiers

DOI

10.1158/1078-0432.CCR-06-0474

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16951238

retrieved

12 May 2018

reference URL

http://europepmc.org/abstract/MED/16951238

PubMed publication ID

16951238

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16951238

retrieved

12 May 2018

reference URL

http://europepmc.org/abstract/MED/16951238

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53250395&oldid=1694237348"